|
HS Code |
827999 |
| Generic Name | Nystatin |
| Brand Names | Mycostatin, Nyamyc, Nystop |
| Drug Class | Polyene antifungal |
| Indications | Treatment of fungal infections, primarily caused by Candida species |
| Route Of Administration | Oral, topical, vaginal |
| Mechanism Of Action | Binds to ergosterol in fungal cell membrane, causing cell contents to leak |
| Prescription Status | Prescription only |
| Dosage Forms | Suspension, cream, ointment, powder, tablet, lozenge |
| Side Effects | Nausea, vomiting, diarrhea, skin irritation, rash |
| Contraindications | Known hypersensitivity to nystatin or any component of the formulation |
| Storage Conditions | Store at 20° to 25°C (68° to 77°F) |
As an accredited Nystatin factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Nystatin comes in a white, rectangular cardboard box containing 100,000 units/mL, 24 mL bottle, clearly labeled with dosage and instructions. |
| Shipping | Nystatin should be shipped in tightly closed, light-resistant containers at controlled room temperature (20–25°C). Protect from moisture and excessive heat. For bulk quantities, use adequate secondary containment to prevent spills. Ensure packaging complies with applicable regulations for pharmaceuticals. Avoid freezing and handle with care to maintain product integrity during transit. |
| Storage | Nystatin should be stored at a controlled room temperature, typically between 20°C and 25°C (68°F to 77°F). It must be kept tightly closed in a well-sealed container, protected from moisture, heat, and direct light. Avoid freezing and keep out of reach of children. For optimal stability, follow the manufacturer's storage guidelines provided with the product. |
Competitive Nystatin prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to sales3@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: sales3@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Nystatin carries a long record in the pharmaceutical and food sectors as a broad-spectrum polyene antifungal agent. Its story starts with fermentation-derived actinomycete strains and continues through rigorous downstream purification. We have manufactured nystatin for over two decades, refining each batch to achieve tight quality controls. The finished product finds its primary use in both topical and oral antifungal therapies. The model we provide, Nystatin USP/EP grade, comes in several specifications tailored to production requirements in pharmaceuticals and feed additives.
Few realize how hands-on nystatin’s manufacturing process needs to be. Unlike synthetic chemicals, nystatin emerges through a live fermentation with a specific Streptomyces species. Throughout every stage—fermentation, separation, concentration, purification—minute adjustments can mean the difference between a batch that passes or fails. Temperature, pH, aeration, feed cycles, even the age of the seed culture: all need regular observation and fine-tuning by experienced operators. As a producer, we have watched how subtle fermentation dynamics predict yield and purity, prompting us to invest in upgraded bioreactors, sensor systems, and multi-step solid-liquid separation.
Once the culture matures, careful solvent extraction and crystallization drive the active principle out of the broth. Losses in recovery here easily erode yields. After hundreds of cycles, crews learn that a consistent rhythm beats raw automation. Every harvest, operators sample the intermediate material to track both active nystatin content and contaminant levels. Bioburden and potency checks go hand in hand. At every sampling point, we test for both activity and absence of unwanted microbial byproducts. This tight process discipline builds the foundation of our product’s reliability.
Nystatin’s potency is measured in International Units (IU), a value locked to biological activity against standard fungal targets. Our production typically delivers 4,000,000 to 5,000,000 IU/g in the final dry powder, with low water and ash contents. These numbers matter—too broad a potency range puts formulators at risk for overdoses or underdoses. Through careful cell culture management, precise downstream workup, and controlled drying, we have kept our output consistent batch to batch.
Unlike many raw ingredients, pure nystatin rarely ships direct to the end user except into laboratories. Instead, most pharmaceutical companies receive it as a stable, micro-milled yellowish powder, ready for compounding in topical creams, oral suspensions, lozenges, or vaginal tablets. Overmixing, heat, or light exposure during final product blending can degrade its activity. We communicate this to clients who run granulation or spray drying. Our technical team runs parallel tests on stability—real time and accelerated—to inform optimal storage and formulation practices. Excessive emphasis on chase for high yield often creates unstable forms, but the balance of purity, stability, and yield reflects hard-earned trade-offs.
In human health, nystatin dominates as a frontline defense against Candida species in both skin and gastrointestinal settings. It stands apart from synthetic azoles by its lack of systemic absorption: patients with mucosal or topical fungal infections get effective local treatment without major risk of systemic toxicity. The same safety benefit drove food and feed producers to adopt it as a safeguard against mold and yeast proliferation in sensitive mixes. In the dairy industry, nystatin keeps fungal contaminants from spoiling starter cultures. With the rise in immunosuppressed patients and wider livestock application, demand for nystatin has steadily grown.
Handling and incorporating nystatin is equally familiar to smaller compounding pharmacies and full-scale cGMP pharmaceutical plants. Its water-insolubility shapes how formulators use it—creams, ointments, and oral suspensions all require thorough dispersion to assure even distribution. Some generic manufacturers push slurry homogenization or bead-milling technology to achieve finer particle sizes. Feed producers often blend microfine nystatin directly into dry or wet mixes; our production specialists share these technical realities with clients who value practical advice over generic instructions.
Industry professionals commonly group nystatin with other polyene or azole antifungal agents, but the practical differences have real-world effects. Amphotericin B, another polyene, shows higher systemic potency but much greater potential for side effects—it isn’t safe for local or oral use in the same way. Azoles such as clotrimazole or fluconazole, completely synthetic, offer systemic options and tastelessness in oral forms, but select for resistance more quickly and can interact with other medications. Nystatin, through its unique mechanism—binding to ergosterol in fungal membranes—shows a resistance profile that has held up for decades. It has a proven safety record even in infants, the elderly, and immune-compromised settings.
Our experience supplying global clients highlights ongoing regulatory, analytical, and formulation challenges that set nystatin apart. In some regions, authorities apply stricter purity demands. Some buyers require absence of genetically modified organisms, placing pressure on the upstream fermentation process. We work closely across our analytics, QA, and regulatory teams to provide detailed documentation and full traceability from the initial fermentation input down to the batch certificate.
Several hurdles face the nystatin industry: rising input costs, stricter regulations, and the interplay between industrial-scale demands and niche formulation requirements. All affect how a manufacturer approaches efficiency and sustainability. High-quality fermentation feeds, energy-efficient downstream lines, and reduced solvent use now occupy more of our process optimization effort than any time in the past.
A big lesson comes from impurity profiling. We have seen that precision in seed culture handling, substrate sterilization, and timely downstream harvesting restricts the formation of ‘side’ polyenes and breakdown products. Through in-house HPLC and bioassay systems, batches failing our low impurity thresholds don’t progress to drying or packaging. Years of tracking customer feedback have shown the risks when substandard batches make it to market: reduced shelf-life, unpleasant flavors, even outright regulatory recalls. Transparency and active customer dialogue help avoid these scenarios.
Today’s market asks for more than minimum compliance. Veterinary-grade clients request tailored granulation, lower dusting, or customized combinations with other antimicrobials. Pharmaceutical customers press for tighter residual solvent control, micro-fine grades, or further confirmation of identity. Instead of pushing all clients to a one-size-fits-all solution, we work directly with QA and R&D teams to troubleshoot and match the best fit. Our technical support staff often walk customers through solubility, particle sizing, and dispersion protocols developed over years in production.
Nystatin sourcing remains concentrated among a handful of global manufacturers. Pharmaceutical companies and food producers benefit from stability, but disruptions—raw material scarcities, geopolitical obstacles, or regulatory shifts—can ripple through the industry. Unlike repackagers or traders, our staff see ingredient quality long before it ships. Orders sometimes come under pressure for faster turnaround, yet skipping proper fermentation, testing, or secondary purification means substandard nystatin. When cost pressures rise, a true manufacturer’s responsibility is maintaining quality and full compliance above all else.
Long-term clients often visit our facility to witness audit trails and process controls in real time. They want answers from the people who actually manage the fermenters, sampling, QCs, and packaging lines day after day—not from remote sales teams. In our experience, customer trust grows only through access and unedited transparency.
Industry-wide attention has shifted toward environmental impact. The solvents and water volumes involved in nystatin production have posed challenges for downstream waste treatment. To reduce our footprint, we have introduced more efficient evaporation and solvent recovery units along with membrane filtration for water recycling. Raw materials are sourced with stricter traceability and sustainability certifications to support both customer and regulatory requirements. Even small process tweaks—reusing extracted media for preliminary washes, implementing closed-vessel fermentation—have led to notable reductions in emissions and effluent volumes.
Innovation doesn’t end with compliance. Customers request new delivery systems for antifungals that nystatin can’t always meet in its classic powder status. Pressure grows for injectable or novel nano-formulated nystatin, for better handling and improved shelf stability. As a manufacturer rooted in the core production process, we maintain pilot-scale facilities for collaboration with research teams working on encapsulation, improved dispersibility, and combination antifungal products.
Technical partnerships further drive continuous upgrade in quality. On more than one occasion, our own staff have collaborated with external scientists examining rare polymorphs, crystallinity, and impurity fingerprints. These projects feed back into our main production streams, letting us target both regulatory and practical improvements.
Practical challenges don’t end after manufacturing wraps up. Nystatin’s physical properties can lead to dusting during handling, occasional caking, and subpar redispersibility in high-speed blending. Our packing and logistics crew take pride in minimizing losses at these stages. The right packaging—double-lined kraft drums or sealed polyethylene bags—prevents both moisture ingress and contamination. Our logistics partners get clear instructions for storage and transit: avoid extremes of heat and humidity, never stack past weight-rated limits, and maintain FIFO discipline.
Once the product leaves our site, we help with technical insights on blending and end-use mixing. End-user feedback matters. Years ago, a series of field complaints about slow suspension in syrups led us to improve our micro-milling systems, cutting agglomeration and caking rates in the process. We keep open channels for such direct feedback—mistakes and learning drive process upgrades as much as audits ever will.
No machine or software system can substitute for operators with years spent monitoring the bubbling fermenter tanks, tweaking air rates, taste-testing intermediate product, and running final analytical checks. In our plant, the most experienced staff share stories of both close calls and small discoveries, letting the next generation learn practical skills for safeguarding quality. That depth of skill—hard-won through hands-on repetition—forms the core of reliable nystatin output.
We continuously refine internal training, emphasizing safe material handling, hygiene, and the “whys” behind each step. New operators attend briefings with chemists and QA leads, walking the line from seed bank to loading dock, seeing at each phase how minor deviations can upend finished batch quality. This people-centered approach supports our commitment not just to compliance, but to continuous improvement.
Nystatin has earned its place as a vital antifungal for health, food, and feed applications through decades of demonstrated reliability, safety, and unique local action. Experienced manufacturing underpins the stability and safety customers rely on. True value grows not from chasing price alone, but through deeper relationships, process transparency, and hands-on attention to quality and innovation. For us, each shipment represents months of meticulous cultivation, careful processing, and real-world learning—bridging the gap between raw science and daily application.